FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012881024> ?p ?o ?g. }

• W2012881024 endingPage "123" @default.
• W2012881024 startingPage "115" @default.
• W2012881024 abstract "We established short-term cell lines for 108/170 (64%) patients with metastatic melanoma. Tumor cell numbers were expanded to 10(8), then cells were irradiated, aliquoted, and cryopreserved for clinical use. Vaccines have been used to treat 69 patients with clinical follow up for 33 who had measurable metastatic disease at the time vaccine therapy was initiated (METS), and 33 who had no evidence of disease (NED) at the time of vaccine therapy following surgical resection of metastases. The protocol called for a baseline test of delayed tumor hypersensitivity (DTH), three weekly injections, a repeat of the DTH test, then monthly injections for an additional 5 months. Objective tumor responses were noted in 3/26 (12%) patients who received a minimum of three vaccinations, one complete, and two partial, with survivals of 36, 46+, and 78+ months. Only 6/64 (9.4%) had a positive DTH (>10 mm) at baseline, including three METS, all of whom progressed within 4 months and died within a year, and three who are still NED after more than 5 years. Conversion of DTH from negative to positive was documented in 18/44 (41%) patients who were tested at week 0 and 4. At a median follow up of greater than 5 years, the median overall survival (OS) was 40 months for NED with a 5-year survival rate of 39%, and 8.6 months with a 5-year survival rate of 10% for METS The 18 patients who had conversion of their DTH had a median event-free survival (EFS) of 15.8 months and 5-year EFS of 32% compared to 4.2 months and 9% for the 26 non-converters (P=0.012, two-tailed, log-rank test). Among patients who were NED when treatment started, the 12 patients whose DTH converted had a median overall survival of 61.4 months with 5-year survival of 63% compared to 9.7 months and 0% for the 13 non-converters (P=0.0026). This treatment approach is feasible, produces minimal toxicity, and is associated with long-term survival in a significant subset of patients." @default.
• W2012881024 created "2016-06-24" @default.
• W2012881024 creator A5005033200 @default.
• W2012881024 creator A5005467280 @default.
• W2012881024 creator A5010771345 @default.
• W2012881024 creator A5013377891 @default.
• W2012881024 creator A5019015178 @default.
• W2012881024 creator A5022470842 @default.
• W2012881024 creator A5050428388 @default.
• W2012881024 creator A5069662888 @default.
• W2012881024 creator A5072563567 @default.
• W2012881024 date "2001-08-01" @default.
• W2012881024 modified "2023-10-17" @default.
• W2012881024 title "Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma" @default.
• W2012881024 cites W1502284045 @default.
• W2012881024 cites W1516736824 @default.
• W2012881024 cites W1752324982 @default.
• W2012881024 cites W1866549327 @default.
• W2012881024 cites W1986523328 @default.
• W2012881024 cites W2004848111 @default.
• W2012881024 cites W2008404672 @default.
• W2012881024 cites W2013411992 @default.
• W2012881024 cites W2024240420 @default.
• W2012881024 cites W2034355989 @default.
• W2012881024 cites W2043950983 @default.
• W2012881024 cites W2056238387 @default.
• W2012881024 cites W2056804333 @default.
• W2012881024 cites W2057189260 @default.
• W2012881024 cites W2067274296 @default.
• W2012881024 cites W2067573891 @default.
• W2012881024 cites W2081774451 @default.
• W2012881024 cites W2091381558 @default.
• W2012881024 cites W2092390196 @default.
• W2012881024 cites W2107979105 @default.
• W2012881024 cites W2239850217 @default.
• W2012881024 cites W2243393118 @default.
• W2012881024 cites W2321689187 @default.
• W2012881024 cites W3041047318 @default.
• W2012881024 doi "https://doi.org/10.1016/s1040-8428(01)00110-x" @default.
• W2012881024 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11418308" @default.
• W2012881024 hasPublicationYear "2001" @default.
• W2012881024 type Work @default.
• W2012881024 sameAs 2012881024 @default.
• W2012881024 citedByCount "29" @default.
• W2012881024 countsByYear W20128810242015 @default.
• W2012881024 countsByYear W20128810242021 @default.
• W2012881024 countsByYear W20128810242023 @default.
• W2012881024 crossrefType "journal-article" @default.
• W2012881024 hasAuthorship W2012881024A5005033200 @default.
• W2012881024 hasAuthorship W2012881024A5005467280 @default.
• W2012881024 hasAuthorship W2012881024A5010771345 @default.
• W2012881024 hasAuthorship W2012881024A5013377891 @default.
• W2012881024 hasAuthorship W2012881024A5019015178 @default.
• W2012881024 hasAuthorship W2012881024A5022470842 @default.
• W2012881024 hasAuthorship W2012881024A5050428388 @default.
• W2012881024 hasAuthorship W2012881024A5069662888 @default.
• W2012881024 hasAuthorship W2012881024A5072563567 @default.
• W2012881024 hasConcept C121608353 @default.
• W2012881024 hasConcept C126322002 @default.
• W2012881024 hasConcept C141071460 @default.
• W2012881024 hasConcept C203014093 @default.
• W2012881024 hasConcept C22070199 @default.
• W2012881024 hasConcept C2776283816 @default.
• W2012881024 hasConcept C2777658100 @default.
• W2012881024 hasConcept C2777701055 @default.
• W2012881024 hasConcept C502942594 @default.
• W2012881024 hasConcept C71924100 @default.
• W2012881024 hasConcept C90924648 @default.
• W2012881024 hasConceptScore W2012881024C121608353 @default.
• W2012881024 hasConceptScore W2012881024C126322002 @default.
• W2012881024 hasConceptScore W2012881024C141071460 @default.
• W2012881024 hasConceptScore W2012881024C203014093 @default.
• W2012881024 hasConceptScore W2012881024C22070199 @default.
• W2012881024 hasConceptScore W2012881024C2776283816 @default.
• W2012881024 hasConceptScore W2012881024C2777658100 @default.
• W2012881024 hasConceptScore W2012881024C2777701055 @default.
• W2012881024 hasConceptScore W2012881024C502942594 @default.
• W2012881024 hasConceptScore W2012881024C71924100 @default.
• W2012881024 hasConceptScore W2012881024C90924648 @default.
• W2012881024 hasIssue "1-2" @default.
• W2012881024 hasLocation W20128810241 @default.
• W2012881024 hasLocation W20128810242 @default.
• W2012881024 hasOpenAccess W2012881024 @default.
• W2012881024 hasPrimaryLocation W20128810241 @default.
• W2012881024 hasRelatedWork W2002120878 @default.
• W2012881024 hasRelatedWork W2003938723 @default.
• W2012881024 hasRelatedWork W2047967234 @default.
• W2012881024 hasRelatedWork W2118496982 @default.
• W2012881024 hasRelatedWork W2364998975 @default.
• W2012881024 hasRelatedWork W2369162477 @default.
• W2012881024 hasRelatedWork W2439875401 @default.
• W2012881024 hasRelatedWork W2981372661 @default.
• W2012881024 hasRelatedWork W4238867864 @default.
• W2012881024 hasRelatedWork W2525756941 @default.
• W2012881024 hasVolume "39" @default.
• W2012881024 isParatext "false" @default.
• W2012881024 isRetracted "false" @default.
• W2012881024 magId "2012881024" @default.

• next